Showing results (3271-3280 of 6,511) with videos related to
Sort By:
Pageof 652
Experimental Hematology|February 26, 2016
Evaluation of GMP-compliant culture media for in vitro expansion of human bone marrow mesenchymal stromal cellsPatrick Wuchter, Marcel Vetter, Rainer Saffrich, et al.Experimental Hematology|May 1, 1989
In vitro growth of rat bone marrow BFU-ER C Meagher, S A Rothmann, I K Paik, et al.Experimental Hematology|May 30, 2015
Targeted gene correction of RUNX1 in induced pluripotent stem cells derived from familial platelet disorder with propensity to myeloid malignancy restores normal megakaryopoiesisHiromitsu Iizuka, Yuki Kagoya, Keisuke Kataoka, et al.Experimental Hematology|January 10, 2025
A distinct alternative mRNA splicing profile identifies the oncogenic CD44 transcript variant 3 in KMT2A-rearranged pediatric T-cell acute lymphoblastic leukemia cellsAmanda Ramilo Amor, Sabina Enlund, Indranil Sinha, et al.Experimental Hematology|January 5, 2025
The diagnostic and therapeutic potential of multiple myeloma-associated circular RNAsYue Zhao, Shaokun Wang, Shuang Fu, et al.Experimental Hematology|November 30, 2024
Sex-stratified association of variants in the serotonin 1A receptor gene with acute crisis pain among African American patients with sickle cell diseaseNilanjana Sadhu, Ying He, Yavnika Kashyap, et al.Experimental Hematology|December 18, 2024
The inhibitory receptor PVRIG is dominantly expressed in the bone marrow of patients with multiple myeloma and its blockade enhances T-cell engager's immune activationMasha Frenkel, Zoya Alteber, Ning Xu, et al.Experimental Hematology|November 24, 2024
Microbiome and Hemato-immune AgingAlban Johansson, Nicole Pui-Yu Ho, Hitoshi TakizawaExperimental Hematology|November 24, 2024
Differential impact of CD34+ cell dose for different age groups in allogeneic hematopoietic cell transplantation for acute leukemia: a machine learning-based discoveryYiyang Qu, Hamed Shourabizadeh, Aravind Subramanian, et al.Experimental Hematology|September 30, 2025
Upfront menin-inhibitor resistance in multiply pretreated leukemiasLeila Mahdavi, Fatemeh Alikarami, Haley Goodrow, et al.Pageof 652